Who Paid My Doc
Elranatamab Clinical Publication Program
Research payments
$355,210
Through program year 2025, $355,210 in research payments was reported against Elranatamab Clinical Publication Program, across 513 payments, paid by Pfizer Inc..
- Paid by
- Pfizer Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $66,960 | 105 |
| 2024 | Research | $28,700 | 40 |
| 2023 | Research | $167,480 | 199 |
| 2022 | Research | $46,760 | 83 |
| 2021 | Research | $45,310 | 86 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
1 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.